Healthcare Reports

PD-1 and PDL-1 Inhibitors Market Size, Insight and Forecast to 2032. Market Focus on Epidemiology, Product, and Region.

In 2021, the global 3D protein structure analysis market was valued at $1,017.2 million, and it is expected to reach $2,676.6 million by 2032, growing at a CAGR of 9.32% during the forecast period 2022-2032.

Numerous advancements in flow cytometry have made it possible to conduct an increasing number of cancer research studies

The market has been divided into web and cloud based. Currently, the global AI-enabled medical imaging solutions market has been dominated by cloud-based solutions with shares of 64.72% in 2019. The cloud- and web-based solutions segment are supposed to grow at a CAGR of 26.96%.

Nutrigenomics aims to elucidate the impact of diet on human health. The increasing rate of obesity and lifestyle-related diseases has led to the rise in the focus on diet-related changes in metabolism and gene. The increasing awareness for genetic testing and nutrigenomic diet such as prebiotic and probiotic food has majorly attributed to the growing prominence for nutrigenomics.

Laboratory informatics software has emerged as a specialist application. It consists of several technological instruments.

 The global emerging sleep apnea devices and platforms market is projected to reach up to $
13,179.6 million by 2030, witnessing a compound annual growth rate (CAGR) of 9.94% during
the forecast period 2021-2030. 

The growth of the epigenetics market is expected to be driven by the decrease in the cost of sequencing, the global increase in the application of next-generation sequencing, and the advancement of the products. Among all applications of epigenetics, oncology accounted for the largest share in 2020, holding 52.01% of the market.

The biomedical segment currently dominates the global CRISPR gene editing market and is anticipated to remain dominant during the forecast period 2021-2031.
The dominance is attributed to the rising geriatric population, increasing prevalence of chronic diseases, and increasing investments from biopharmaceutical companies. The fastest-growing segment in biomedical is expected to be drug discovery, with a CAGR of 27.86% during the forecast period 2021-2031.

NIPT market as one of the most rapidly evolving markets amongst the other prenatal testing industries. The growth in the market is attributed to the increasing reimbursement policies and insurance coverage across the globe. Further, the continued significant investments for genome sequencing by healthcare companies to meet the industry demand and the growing incidence of genetic disorders are the prominent factors propelling the growth of the global NIPT market.

Genetic testing is gaining significant prominence globally. Genetic testing is considered a crucial tool for the prevention of different malignancies.

Women's health diagnostics are important for identifying and treating health issues that are specific to women.

NGS informatics is a field that involves using computational and statistical methods to analyze and interpret data produced by NGS technologies.

Using MRI-guided targeted biopsy or MRI-ultrasound fusion with PSA screening, it is possible to precisely pinpoint and sample suspicious tumors.

Adoption of dose management software solutions is primarily expected to witness a shift from hospitals to diagnostic centers

Though the global molecular oncology diagnostics market is a well-established market, due to the continuous increase in the demand for innovative products.

Wearable patches can measure body movement, blood pressure, and heart rate, detect and monitor arrhythmia, and support exercise training and rehabilitation.

Lung cancer disease is characterized by an abnormal growth of the cells present in the lungs. As a result, the patient experiences basic symptoms such as shortness of breath, chest pain, and heaviness that eventually lead to the cancer cells spreading to other parts of the body